X chromosome choice occurs independently of asynchronous replication timing

Por Gribnau, Joost, Luikenhuis, Sandra, Hochedlinger, Konrad, Monkhorst, Kim, Jaenisch, Rudolf
Publicado em 2005

Generation and characterization of an inducible transgenic model for studying mouse esophageal biology

Por Roth, Sabrina, Franken, Patrick, Monkhorst, Kim, Kong a San, John, Fodde, Riccardo
Publicado em 2012

Buccal swab as a reliable predictor for X inactivation ratio in inaccessible tissues

Por de Hoon, Bas, Monkhorst, Kim, Riegman, Peter, Laven, Joop S E, Gribnau, Joost
Publicado no J Med Genet (2015)

Xist RNA Is Confined to the Nuclear Territory of the Silenced X Chromosome throughout the Cell Cycle

Por Jonkers, Iris, Monkhorst, Kim, Rentmeester, Eveline, Grootegoed, J. Anton, Grosveld, Frank, Gribnau, Joost
Publicado em 2008

SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin

Por Ferone, Giustina, Song, Ji-Ying, Sutherland, Kate D., Bhaskaran, Rajith, Monkhorst, Kim, Lambooij, Jan-Paul, Proost, Natalie, Gargiulo, Gaetano, Berns, Anton
Publicado no Cancer Cell (2016)

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment

Por de Langen, Adrianus J., Jebbink, M., Hashemi, Sayed M. S., Kuiper, Justine L., de Bruin-Visser, J., Monkhorst, Kim, Thunnissen, Erik, Smit, Egbert F.
Publicado no Br J Cancer (2018)

Relation between intra-abdominal pressure and early intestinal ischemia in rats

Por Strang, Steven G, van der Hoven, Ben, Monkhorst, Kim, Ali, Samir, van Lieshout, Esther M M, van Waes, Oscar J F, Verhofstad, Michael H J
Publicado no Trauma Surg Acute Care Open (2020)

The Probability to Initiate X Chromosome Inactivation Is Determined by the X to Autosomal Ratio and X Chromosome Specific Allelic Properties

Por Monkhorst, Kim, de Hoon, Bas, Jonkers, Iris, Mulugeta Achame, Eskeatnaf, Monkhorst, Wouter, Hoogerbrugge, Jos, Rentmeester, Eveline, Westerhoff, Hans V., Grosveld, Frank, Grootegoed, J. Anton, Gribnau, Joost
Publicado em 2009

Activation of the β globin locus by transcription factors and chromatin modifiers

Por McMorrow, Tara, van den Wijngaard, Arthur, Wollenschlaeger, Alex, van de Corput, Mariëtte, Monkhorst, Kim, Trimborn, Tolleiv, Fraser, Peter, van Lohuizen, Maarten, Jenuwein, Thomas, Djabali, Malek, Philipsen, Sjaak, Grosveld, Frank, Milot, Eric
Publicado em 2000

Formalin fixation for optimal concordance of programmed death‐ligand 1 immunostaining between cytologic and histologic specimens from patients with non–small cell lung cancer

Por Koomen, Bregje M., van der Starre‐Gaal, Jose, Vonk, Judith M., von der Thüsen, Jan H., van der Meij, Jacqueline J. C., Monkhorst, Kim, Willems, Stefan M., Timens, Wim, ’t Hart, Nils A.
Publicado no Cancer Cytopathol (2020)

T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production

Por van Asten, Saskia D., de Groot, Rosa, van Loenen, Marleen M., Castenmiller, Suzanne M., de Jong, Jeroen, Monkhorst, Kim, Haanen, John B.A.G., Amsen, Derk, Bex, Axel, Spaapen, Robbert M., Wolkers, Monika C.
Publicado no Oncoimmunology (2021)

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer

Por Schouten, Robert D., Vessies, Daan C. L., Bosch, Linda J. W., Barlo, Nicole P., van Lindert, Anne S. R., Cillessen, Saskia A. G. M., van den Broek, Daan, van den Heuvel, Michel M., Monkhorst, Kim
Publicado no JCO Precis Oncol (2021)

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions

Por Hummelink, Karlijn, Muller, Mirte, Linders, Theodora C., van der Noort, Vincent, Nederlof, Petra M., Baas, Paul, Burgers, Sjaak, Smit, Egbert F., Meijer, Gerrit A., van den Heuvel, Michel M., van den Broek, Daan, Monkhorst, Kim
Publicado no ERJ Open Res (2019)

Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer

Por van Brummelen, Emilie M.J., Huijberts, Sanne, van Herpen, Carla, Desar, Ingrid, Opdam, Frans, van Geel, Robin, Marchetti, Serena, Steeghs, Neeltje, Monkhorst, Kim, Thijssen, Bas, Rosing, Hilde, Huitema, Alwin, Beijnen, Jos, Bernards, Rene, Schellens, Jan
Publicado no Oncologist (2020)

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer: Results of the PEMBRO-RT...

Por Theelen, Willemijn S. M. E., Peulen, Heike M. U., Lalezari, Ferry, van der Noort, Vincent, de Vries, Jeltje F., Aerts, Joachim G. J. V., Dumoulin, Daphne W., Bahce, Idris, Niemeijer, Anna-Larissa N., de Langen, Adrianus J., Monkhorst, Kim, Baas, Paul
Publicado no JAMA Oncol (2019)

Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice

Por Badhai, Jitendra, Pandey, Gaurav Kumar, Song, Ji-Ying, Krijgsman, Oscar, Bhaskaran, Rajith, Chandrasekaran, Gayathri, Kwon, Min-chul, Bombardelli, Lorenzo, Monkhorst, Kim, Grasso, Cristoforo, Zevenhoven, John, van der Vliet, Jan, Cozijnsen, Miranda, Krimpenfort, Paul, Peeper, Daniel, van Lohuizen, Maarten, Berns, Anton
Publicado no J Exp Med (2020)

Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer

Por Theelen, Willemijn S. M. E., Kuilman, Thomas, Schulze, Katja, Zou, Wei, Krijgsman, Oscar, Peters, Dennis D. G. C., Cornelissen, Sten, Monkhorst, Kim, Sarma, Pranamee, Sumiyoshi, Teiko, Amler, Lukas C., Willems, Stefan M., Blaauwgeers, Johannes L. G., van Noesel, Carel J. M., Peeper, Daniel S., van den Heuvel, Michel M., Kowanetz, Marcin
Publicado no PLoS One (2019)

Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

Por Semenova, Ekaterina A., Kwon, Min-chul, Monkhorst, Kim, Song, Ji-Ying, Bhaskaran, Rajith, Krijgsman, Oscar, Kuilman, Thomas, Peters, Dennis, Buikhuisen, Wieneke A., Smit, Egbert F., Pritchard, Colin, Cozijnsen, Miranda, van der Vliet, Jan, Zevenhoven, John, Lambooij, Jan-Paul, Proost, Natalie, van Montfort, Erwin, Velds, Arno, Huijbers, Ivo J., Berns, Anton
Publicado no Cell Rep (2016)

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)

Por Samsom, Kris G., Bosch, Linda J. W., Schipper, Luuk J., Roepman, Paul, de Bruijn, Ewart, Hoes, Louisa R., Riethorst, Immy, Schoenmaker, Lieke, van der Kolk, Lizet E., Retèl, Valesca P., Frederix, Geert W. J., Buffart, Tineke E., van der Hoeven, Jacobus J. M., Voest, Emile E., Cuppen, Edwin, Monkhorst, Kim, Meijer, Gerrit A.
Publicado no BMC Med Genomics (2020)

Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile

Por De Groot, Rosa, Van Loenen, Marleen M., Guislain, Aurélie, Nicolet, Benoît P., Freen-Van Heeren, Julian J., Verhagen, Onno J.H.M., Van Den Heuvel, Michel M., De Jong, Jeroen, Burger, Patrick, Van Der Schoot, C.Ellen, Spaapen, Robbert M., Amsen, Derk, Haanen, John B. A. G., Monkhorst, Kim, Hartemink, Koen J., Wolkers, Monika C.
Publicado no Oncoimmunology (2019)